Enanta Pharmaceuticals (ENTA) Change in Cash (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Change in Cash of -$2.5 million for Q1 2026, up 89.86% year-on-year from -$1.3 million in Q1 2025, and down 148.82% on a QoQ basis from $5.1 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Change in Cash data on file, last reported at -$2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 89.86% year-over-year to -$2.5 million; the trailing twelve-month figure through Mar 2026 stood at -$25.3 million (down 542.24% YoY), and the FY2025 full-year result was -$5.5 million, up 88.49% from the prior year.
- Change in Cash for Q1 2026 stood at -$2.5 million, down from $5.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $47.1 million in Q4 2024 and bottomed at -$58.1 million in Q1 2022.
- The 5-year median for Change in Cash is -$2.5 million (2026), against an average of -$3.6 million.
- Peak annual rise in Change in Cash reached 337.52% in 2023, while the deepest fall reached 2466.63% in 2023.
- A 5-year view of Change in Cash shows it stood at -$1.8 million in 2022, then tumbled by 2466.63% to -$45.5 million in 2023, then jumped by 203.65% to $47.1 million in 2024, then sank by 89.09% to $5.1 million in 2025, then plunged by 148.82% to -$2.5 million in 2026.
- The last three Change in Cash figures came in at -$2.5 million (Q1 2026), $5.1 million (Q4 2025), and -$12.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -2.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.51 Mn |
| Dec 31, 2025 | 5.14 Mn |
| Sep 30, 2025 | -12.51 Mn |
| Jun 30, 2025 | -15.40 Mn |
| Mar 31, 2025 | -24.74 Mn |
| Dec 31, 2024 | 47.12 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | -27.77 Mn |
| Mar 31, 2024 | 23.61 Mn |
| Dec 31, 2023 | -45.46 Mn |
| Sep 30, 2023 | -9.79 Mn |
| Jun 30, 2023 | 22.00 Mn |
| Mar 31, 2023 | 30.96 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Sep 30, 2022 | 15.63 Mn |
| Jun 30, 2022 | -9.26 Mn |
| Mar 31, 2022 | -58.08 Mn |
| Dec 31, 2021 | 41.86 Mn |
| Sep 30, 2021 | 52.61 Mn |
| Jun 30, 2021 | -72.53 Mn |
| Mar 31, 2021 | 22.03 Mn |
| Dec 31, 2020 | -32.04 Mn |
| Sep 30, 2020 | -12.72 Mn |
| Jun 30, 2020 | 25.52 Mn |
| Mar 31, 2020 | 46.78 Mn |
| Dec 31, 2019 | -23.67 Mn |
| Sep 30, 2019 | -42.98 Mn |
| Jun 30, 2019 | -11.82 Mn |
| Mar 31, 2019 | 31.67 Mn |
| Dec 31, 2018 | 10.46 Mn |
| Sep 30, 2018 | 21.43 Mn |
| Jun 30, 2018 | -24.45 Mn |
| Mar 31, 2018 | -1.13 Mn |
| Dec 31, 2017 | 2.38 Mn |
| Sep 30, 2017 | 43.41 Mn |
| Jun 30, 2017 | 3.05 Mn |
| Mar 31, 2017 | -1.41 Mn |
| Dec 31, 2016 | 4.04 Mn |
| Sep 30, 2016 | -8.21 Mn |
| Jun 30, 2016 | -31.57 Mn |
| Mar 31, 2016 | 10.13 Mn |
| Dec 31, 2015 | 24.51 Mn |
| Sep 30, 2015 | 1.88 Mn |
| Jun 30, 2015 | -5.91 Mn |
| Mar 31, 2015 | -8.38 Mn |
| Dec 31, 2014 | 3.43 Mn |
| Sep 30, 2014 | 4.33 Mn |
| Jun 30, 2014 | 8.27 Mn |
| Mar 31, 2014 | 13.68 Mn |
| Dec 31, 2013 | -4.43 Mn |
| Sep 30, 2013 | -10.02 Mn |
| Jun 30, 2013 | -55.59 Mn |
| Mar 31, 2013 | 53.73 Mn |
| Dec 31, 2012 | 10.22 Mn |
| Sep 30, 2012 | 6.55 Mn |
| Jun 30, 2012 | -16.74 Mn |